TEVA

Teva Pharmaceutical Indu... Share Price - TEVA

11.95
0.45 (3.91%)
11.95
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Teva Pharmaceutical Industries Ltd TEVA NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.45 3.91% 11.95 19:41:12
Open Price Low Price High Price Close Price Prev Close
11.60 11.50 12.06 11.96 11.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
43,261 12,430,477  11.81  146,842,331 9,033,494 6.25 - 13.76
Last Trade Time Type Quantity Stock Price Currency
19:59:31 15  11.95 USD

Teva Pharmaceutical Indu... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 13.10B 1.10B 1.09B  16.89B  -5.90B -0.91 -3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% 392.31k 0.30%

more financials information »

News Teva Pharmaceutical Indu...

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

TEVA Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world with roughly 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.


Your Recent History
NYSE
TEVA
Teva Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.